The potential role of zuclopenthixol acetate in the management of refractory hyperactive delirium at the end of life

J Pain Symptom Manage. 2008 Apr;35(4):336-9. doi: 10.1016/j.jpainsymman.2007.12.002. Epub 2008 Mar 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antipsychotic Agents / therapeutic use*
  • Clopenthixol / analogs & derivatives*
  • Clopenthixol / therapeutic use
  • Delirium / drug therapy*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Palliative Care / methods*
  • Terminal Care / methods*

Substances

  • Antipsychotic Agents
  • clopenthixol acetate ester
  • Clopenthixol